How breast cancer drugs exploit genomic fractures in tumors

Studying families with multiple members who had breast cancer first led to the discovery of mutations in BRCA genes. Doctors have since learned that these mutations increase the risk of developing multiple tumor types, including breast, ovarian, pancreatic and prostate cancers.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup